Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UiPath Inc (PATH) vs Unilever plc (UL) Price & Performance

UiPath IncTrade
Unilever plcTrade

Price performance (Past 24H)

Key statistics

UiPath Inc vs Unilever plc — how do they compare? UiPath Inc trades at $13.32 (market cap $6.91B), while Unilever plc trades at $61.66 (market cap $131.63B). The key difference: Unilever plc is far larger — about 19× UiPath Inc's market cap, and Unilever plc pays a 3.43% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold UiPath Inc for 139 Days and Unilever plc for 112 Days on average.

PATHUL
Market Cap
$6.91B$131.63B
Volume
34,321,2502,978,741
Sector
TechnologyConsumer Staples
52-Week High
$19.29$74.59
52-Week Low
$9.38$55.05
Typical Hold Time
139 Days112 Days
Enterprise Value
$5.70B$156.65B
Dividend Yield
—3.43%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UiPath Inc

UiPath (PATH) trades at $13.07, down 0.23% with bearish technical signals despite strong fundamentals. The company shows improving financials with revenue growth from $1.43B in 2025 to projected $1.7B in 2026, transitioning to profitability with a 21.03% net margin. Recent partnerships with Snowflake and BDO highlight strategic positioning in AI automation, though technical indicators show resistance at $13 with RSI suggesting mixed momentum.

PATH offers compelling value with a P/E of 19.78 and analyst consensus target of $15.13 (16% upside), but faces execution risks and competitive pressure. The stock's bearish technical setup contrasts with fundamental improvement, creating potential for volatility. Investors should weigh strong profitability metrics against recent price weakness and mixed analyst sentiment.

Unilever plc

Unilever (UL) trades at $60.98, up 0.3% on the day, amid a bearish technical outlook and mixed financial performance. Revenue declined to $50.50 billion in 2025, though net income improved to $9.47 billion, with a high net margin of 18.74%. Recent earnings have consistently missed expectations, while the company is streamlining its portfolio through a planned food business merger with McCormick, facing regulatory scrutiny.

The stock presents a cautious outlook with strong profitability metrics like a 54.56% ROE offset by valuation concerns (P/E of 21.59) and earnings misses. Risks include integration challenges from the McCormick deal and competitive pressures, but its focus on beauty and personal care offers growth potential in emerging markets.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PATH
47% Buy53% Sell
Avg holding period · 139 Days
UL
0% Buy100% Sell
Avg holding period · 112 Days

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH →

About Unilever plc

Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years

Read more on UL →